Ovarian cancer is one of the five most common causes of cancer death in women in the USA and UK. It is usually diagnosed when it is well established beyond the ovary in the peritoneum. Intravenous injection of cisplatin is a common palliative therapy for ovarian cancer patients. Intraperitoneal therapy has been shown to improve survival for patients. Poly(lactide-co-glycolide) (PLGA) is a biodegradable polyester which has been proven safe for medical implantation. PLGA microspheres or fibres have been considered in this work as depots for delivering intraperitoneal cisplatin directly to the tumour site. The aims of this work were (1) to develop microsphere depot formulations with improved drug release profiles compared to previous work; (2) Novel cisplatin containing solid and hollow fibres were to be developed and investigated as alternative structures for depot devices; (3) The drug release profiles were to be examined using mathematical models to allow rational comparison of the devices. It was found that cisplatin containing PLGA 65:35 solid and hollow fibres represent a novel, reproducible formulation for encapsulating higher amounts of cisplatin for an equivalent mass of excipient than other polymer formulations. The fibres developed in this study were able to maintain elevated concentrations of unbound cisplatin in the presence of a biological matrix for approximately 100 hours in vitro.

New drugs are needed for better cancer management. Clinical trials are currently underway to assess the use of flavonoids (natural polyphenols) as anticancer agents. Among them, myricetin has been shown to induce cell cycle arrest and apoptosis in pre-clinical cancer models. We hypothesised that myricetin-derived novel flavonoids designed to enhance this natural potential and improve on the drug-likeness limitations of myricetin might have increased potential for their application in the management of breast and ovarian cancer. The effect of a library of novel flavonoids was screened on 3 panels of breast and ovarian cancer cell lines, representing different molecular subtypes and phenotypes, to assess their potency. The second-generation bi-methoxylated analogue AO-1530-OMe (Oncamex) was identified as the most effective candidate in the library, with sub-micromolar concentrations exerting a strong antiproliferative effect across almost all models studied. Results suggested that changes in the hydroxylation profile, the addition of methoxylations and a decyl alkyl chain were some of the structure-activity relationships contributing to this improved efficacy. Plate assays showed 8 h treatment with Oncamex reduced cell viability and induced cytotoxicity and apoptosis, concomitant with caspase activation and PARP cleavage. Pre-incubation with an antioxidant partially blocked these effects, suggesting the possible involvement of ROS modulation in the mechanism of action of Oncamex. Fluorescence microscopy reported the quick and stable delivery of Oncamex to the mitochondria. Fluorescent probes showed that Oncamex can induce mitochondrial superoxide production at concentrations associated with its antiproliferative effects. Study of the electrochemical properties of Oncamex by cyclic voltammetry supported this. Differential gene expression analysis following a microarray experiment showed Oncamex induces changes in the expression of genes controlling cell cycle and apoptosis. Together with previous results, the findings from this analysis led to the postulation of a model for the mechanism of action of Oncamex: due to its enhanced reactivity and mitochondrial targeting, Oncamex can generate mitochondrial superoxide, leading to mitochondrial dysfunction, membrane permeabilisation and the activation of the JNK pathway and the transcription factor FOXO3, which together contribute to the induction of intrinsic apoptosis and the inhibition of proliferation. Further proliferation assays on cell culture models also reported enhanced effect of Oncamex when administered in combination with paclitaxel and TRAIL. These improved responses were observed in breast and ovarian cancer models, including cells lines characterised by their treatment-resistant phenotype. Cotreatment with Oncamex also improved the effect of tamoxifen on anti-oestrogen resistant LCC9 breast cancer cells. Results from preliminary in vivo studies in mice implanted with the MDA-MB-231 breast cancer xenograft were consistent with an antiproliferative effect of Oncamex (25mg/kg/day) in vivo, as treatment inhibited tumour growth and reduced the expression of the marker of proliferation Ki-67 without signs of systemic toxicity. Tissues from this experiment also allowed for preliminary in vivo validation of the proposed mechanism of action of Oncamex by immunohistochemistry. The in vivo cytostatic effect of Oncamex was confirmed in a second in vivo experiment, which also investigated the effect of Oncamex at higher doses or in combination with paclitaxel. In conclusion, the novel flavonoid Oncamex has shown a promising antiproliferative effect in pre-clinical models of breast and ovarian cancer, including models of treatment-resistant cancers. Preliminary in vivo studies have demonstrated a partial recapitulation of the effect of Oncamex. A mechanistic model has been proposed by which Oncamex induces intrinsic apoptosis through its redox reactivity and mitochondrial targeting. These results support the potential of this prototypic candidate, although possible work in the structure and formulation of this candidate and further study and validation of its mechanism of action is needed for its continued development as an anticancer agent.

Background: This thesis is based on a randomised controlled trial comparing the effectiveness of intrauterine insemination (IUI) plus Controlled Ovarian Hyperstimulation (COH) versus in vitro fertilisation (IVF) as the first line treatment option for couples with unexplained subfertility. Subfertility of a couple is classed as unexplained when they fail to conceive after one year of regular unprotected intercourse and when all the standard investigations for ovulation, tubal patency and semen analysis have been found to be normal. It affects 30-40% of couples. The age-old methods of treating these couples have included the empirical use of clomiphene or gonadotrophins to correct any possible subtle defects in ovulation with or without IUI (to overcome any existing cervical barrier to natural conception) or IVF. However, the best treatment options for these couples have yet to be determined. The matter has been made even more controversial by the issue of NICE (National Institute for Health and Care Excellence) guidelines in the UK that suggest IUI be abandoned completely for these women in favour of IVF after 2 years of expectant management. A systematic review of the available literature comparing IUI + COH versus IVF for unexplained subfertility revealed limited numbers of available studies and high clinical and statistical heterogeneity among them. An online survey was also conducted among fertility specialists to establish the general consensus regarding management of such couples. The results revealed a lack of agreement among fertility specialists with regards to the first line treatment of couples with unexplained subfertility. The mixed 8 response to this survey demonstrated the ongoing dilemma among practitioners, much of which was due to the lack of robust evidence. A randomised controlled trial was then designed to examine the effectiveness of COH with gonadotrophins + IUI versus IVF as the first line approach to the treatment of unexplained subfertility (Figure 1). This was the first UK-based randomised controlled trial comparing these two first-line management options for unexplained subfertility.

Protocolos de sucesso para a maturação in vitro de oócitos de peixe são importantes, uma vez que é necessário para garantir uma fertilização bem sucedida, formação do zigoto, crescimento do embrião e seu completo desenvolvimento. Em algumas espécies, a eficiência deste processo ainda é muito baixa ou restrita a poucas substâncias que podem ser utilizadas. Assim, pesquisou-se a utilização de hormônios alternativos ao protocolo já existente para maturação in vitro de ovócitos de zebrafish. O objetivo foi avaliar a eficiência do extrato de hipófise de carpa (EHC), dos hormônios folículo estimulante (FSH) e luteinizante (LH) para fazer a maturação dos ovócitos estádio III de zebrafish. Os oócitos estádio III foram colocados em meio de cultivo Leibovitz modificado, suplementado com soro fetal bovino e adicionado o hormônio correspondente a seu tratamento (T1-controle; T2-16 μg/ml de EHC; T3- 32 μg/ml de EHC; T4- 48 μg/ml de EHC; T5- 64 μg/ml de EHC; T6- 80 μg/ml de EHC; T7- 0,5 μg/ml de FSH; T8- 0,5 μg/ml de LH e T9- 0,5 μg/ml de FSH e 0,5 μg/ml de LH). A taxa de maturação foi avaliada através da visualização da quebra da vesícula germinal (GVBD). Em todos os tratamentos houve maturação, embora o EHC tenha demonstrado taxas de maturação muito baixas (T2= 12,8%; T3=24,8%; T4=27%; T5=22,7%; T6=9,7%) e inferiores em relação a maior eficiência dos hormônios gonadotrópicos (T7=16%; T8=35%; T9=50%). Além disso foi possível verificar a viabilidade dos oócito através da fertilização in vitro do melhor tratamento (T9) com uma taxa de eclosão e desenvolvimento em larva de 60%. Os resultados da maturação in vitro utilizando estes indutores hormonais em oócitos estádio III de zebrafish mostraram-se promissores, e reforçam as perspectivas para o aprimoramento e uso desta técnica para produção in vitro de embriões viáveis. / Successful protocols for maturation of oocytes are important, as it is necessary for ensuring successful fertilization, zygote formation, embryo growth and full development. In some species the efficiency of in vitro maturation is still very low or is still restricted to a little amount of substances which can be used for the matter. Thus, we studied the use of alternative hormones to the existing protocol for in vitro maturation of zebrafish oocytes. The aim of this study was to evaluate the efficiency of the use of carp pituitary extract (CPE), the follicle stimulating hormone (FSH) and luteinizing hormone (LH) to oocyte maturation stage III of zebrafish. Oocytes stage III were placed in modified Leibovitz culture medium, suplemented with fetal bovine serum and added to the correnponding hormone treatment (T1-control; T2-16 g / ml of CHE; T3 32 g / ml of CHE, T4 - 48 g / ml of CHE; T5- 64 g / ml of CHE; T6- 80 g / ml of CHE; T7- 0.5 g / ml of FSH, T8 0.5 mg / ml of LH and T9- 0.5 g / ml of FSH and 0.5 mg / ml LH). The maturation rate was assessed by the germinal vesicle break down (GVBD). In all cases there was maturation, though the EHC has demonstrated fairly low maturation rate (T2= 12,8%; T3=24,8%; T4=27%; T5=22,7%; T6=9,7%) and lower in relation of the high efficiency presented by the gonadotropic hormones (T7=16%; T8=35%; T9=50%). In addition it was possible to verify the viability of the oocyte through IVF of the best treatment (T9) with a result of 60% of hatching and larvae development rate. The results of maturation in turn using this hormones in stage III oocytes of zebrafish proved promising, and enhance the prospects for improvement and use of this technique for in vitro production of viable embryos.

Introdução: A técnica de criopreservação de tecido ovariano tem sido vista como tratamento promissor e se apresenta como a principal maneira de preservar a fertilidade em pacientes pré-púberes e em mulheres que necessitam de tratamento do câncer de imediato. Contudo, atualmente, ainda existem obstáculos em relação ao autotransplante de tecido ovariano criopreservado, devido a fatores como lesão isquêmica, assim como danos causados pelo processo durante o congelamento, bem como a escolha do melhor local para o enxerto. Objetivo: Verificar a possível restauração da função ovariana, analisando a histologia do ovário transplantado em ratas adultas estéreis, após transplante autólogo de tecido ovariano criopreservado em fase pré-púbere. Métodos: Foram utilizadas 45 ratas Wistar com 30 dias de idade, que foram divididas aleatoriamente em três grupos: Grupo Controle (n = 15), férteis normais; Sham (n = 15), submetidas à ooforectomia bilateral; Transplante (n = 15), submetidas à ooforectomia bilateral, seguida de transplante autólogo na região dorsal entre as escápulas. A partir do d35, foram realizadas observações quanto à maturidade sexual, através da análise da abertura vaginal e de esfregaços vaginais, para avaliação do ciclo estral. Após observação da fase do ciclo estral, os animais foram eutanasiados. E, amostras de tecidos foram coletadas e processadas para avaliação histológica dos implantes ovarianos; considerando: organização estrutural do tecido transplantado e adjacente, bem como o desenvolvimento folicular. Resultados: Quanto às avaliações de maturidade sexual, através das análises de abertura vaginal e da análise microscópica do material obtido dos esfregaços vaginais, foi possível observar que os animais do Grupo Controle, que eram férteis ciclaram normalmente. As ratas do Grupo Sham e Transplante não apresentaram ciclo regular, permanecendo em diestro. As avaliações histológicas das amostras de tecido de ovário pré-púbere, implantados em fêmeas adulto jovens, evidenciaram degeneração ovariana; uma vez que estes apresentaram fibrose e áreas de necrose, o que provavelmente impossibilitou o desenvolvimento folicular, nas ratas que receberam o transplante. Conclusão: A técnica de transplante de tecido ovariano em ratas é uma técnica relativamente simples de ser executada, e se mostrou eficaz na manutenção do massa corporal dos animais durante o período observado. Este achado sugere que houve produção hormonal, oriunda do ovário transplantado, fato este que encoraja as pesquisas neste sentido, a fim de se obter uma técnica que restaure a produção de folículos viáveis em pacientes estéreis. Apesar de ter apresentando indícios de falência do enxerto e isquemia no tecido transplantado, os resultados preliminares desta investigação precisam ser complementados com estudos adicionais, a fim de buscar as melhores condições para a obtenção de maior eficácia dos transplantes autólogos de tecido ovarianos criopreservados. / Introduction: Ovarian tissue cryopreservation is a promising treatment and it is presented as the main way to preserve fertility in prepubertal patients and women who need cancer treatment immediately. However still remain obstacles related to the ovarian tissue cryopreserved autograft due to ischemic injury, damage caused by the freezing process and selecting the best location for the graft. Objective: Investigate a possible restoration of the ovarian function by analyzing the histology of the ovary transplanted into sterile adult rats after autologous transplantation of ovarian tissue cryopreserved in prepubertal phase. Methods: 45 Wistar rats, 30 days old,which were randomly divided into three groups: control group (n = 15), normal fertile; Sham group (n = 15), underwent bilateral oophorectomy; Transplantation group (n = 15), underwent bilateral oophorectomy followed by autologous transplantation in the scapular area. From the d35, sexual maturity was observed by examining the vaginal opening and vaginal smears, for evaluation of the estrous cycle. After observing the phase of the estrous cycle, the animals were euthanized. The tissue samples were collected and processed for histological evaluation of ovarian implants; where structural organization of the transplanted tissue and adjacent as well as follicular development were analyzed. Results: Regarding sexual maturity evaluations, observed by vaginal opening analysis and microscopic analysis of material obtained from vaginal swabs, we could observe that the animals in the control group cycled normally. The rats of Sham and Transplant Group showed no regular cycle, staying in diestrus phase. The histological assessments of prepubertal ovarian tissue samples implanted in young adult females showed ovarian degeneration, since they had areas of necrosis and fibrosis, which probably impeded the follicular development in these rats. Conclusion: The ovarian tissue transplantation technique in rats is a relatively simple technique, and is effective in body mass maintenance of animals during the observed period. This finding suggests that there were hormone production originated from the transplanted ovaries, and this, encourages research in order to obtain a technique to restore the production of viable follicles in sterile patients. Despite presenting evidence of graft failure and ischemia in the transplanted tissue, the preliminary results of this investigation need to be supplemented with additional studies in order to get the best conditions for achieving greater effectiveness of autologous transplantation of cryopreserved ovarian tissue.

Introdução: a alta prevalência do câncer e o aumento significativo da sobrevivência em longo prazo geraram interesse quanto à preservação da fertilidade em mulheres jovens expostas a quimioterapia e radioterapia. Neste sentido estudos de congelamento de tecido ovariano para posterior transplante, abriram uma nova perspectiva de aplicação no tratamento e prevenção da infertilidade feminina. Objetivos: comparar dois protocolos de congelamento de tecido ovariano, um lento não automatizado e um por vitrificação, com o intuito de avaliar a viabilidade dos tecidos para posterior transplante autólogo. Método: Foram utilizadas 30 camundongos fêmea CF1 com aproximadamente 8 semanas e pesando 29,29g±2,9. •Os ovários extraídos foram vitrificados ou congelados, mantidos em nitrogênio líquido por 30 dias e descongelados. Após o descongelamento, o ovário esquerdo foi destinado às análises histológicas e caracterização por imuno histoquímica para o marcador mouse vasa homologue (MVH) e o ovário direito foi utilizado para os testes de viabilidade celular com exclusão por azul de trypan. Resultados: Nas análises de Hematoxilina e Eosina (HE) foram contados folículos primordiais, primários, pré-antrais e antrais. Não houve diferença significativa na proporção de folículos primordiais, primários e pré-antrais após descongelamento entre os grupos testados. A contagem de folículos antrais foi significativamente maior no grupo de vitrificação (p = 0,004). No ensaio de imunohistoquímica para o marcador MVH, folículos MVH + e MVH- foram contados e comparados com o número total de folículos. O grupo congelamento lento apresentou maior número de células não marcadas (p = 0,012). Conclusão: Embora ambos os protocolos tenham apresentado resultados semelhantes na análise histológica das contagens foliculares, o protocolo de vitrificação foi significativamente melhor para preservar a população de células tronco ovarianas. / Introduction: The high prevalence of cancer and the significant increase in long-term survival have generated interest as the preservation of fertility in young women exposed to chemotherapy and radiotherapy. Experimental techniques have been tried in an attempt to reverse the ovarian failure induced by these treatments. In this regard studies of ovarian tissue freezing for subsequent transplantation disclose a new application perspective in the treatment and prevention of female infertility. Objective: two ovarian tissue freezing protocols were tested, a non-automated slow-freezing and by vitrification, in order to assess the viability of the tissues for subsequent autologous transplantation. Methods: as ovaries donors, were used 30 female CF1 mice approximately 8 weeks and weighing 29,29g±2,9. • The ovaries were vitrified or frozen, stored in liquid nitrogen for 30 days and thawed. After thawing, the left ovary was intended for histological and immunohistochemical characterization by histochemical marker for MVH and right ovary was used for the tests with cell viability by trypan blue exclusion. Results: In HE slides was counting primordial, primary, pre antral and antral follicles. No significant difference was found in the proportion of high-quality primordial, primary and pre antral follicles after thawing/warming in the slow-freezing and vitrification group, respectively. The antral follicle counting was significant higher in vitrification group (p=0,004). In immunohistochemistry assay for MVH Antibody , MVH+ and MVH- follicles were counted and compared with the total number of follicles and slow freeze group had a higher number of not marked cells (p=0,012). Conclusion: Although both protocols showed similar results in the histological analysis for follicular counts, the vitrification protocol was significantly better for preserve the ovarian stem cell population.

Les données bibliographiques décrivent un nombre croissant de modèles murins caractérisés sur le plan de la fertilité permettant une meilleure compréhension du phénomène de la croissance folliculaire. Certains de ces modèles animaux, invalidés pour des facteurs de transcription reproduisent un phénotype d’infertilité, telle que l’insuffisance ovarienne primaire (IOP). La compréhension des mécanismes moléculaires des facteurs de transcription essentiels à la fonction ovarienne n’est pas clairement établie. Les protéines contenant des domaines liant l’ADN, tels que les homéodomaines ou les domaines forkhead jouent un rôle-Clé dans le développement ovarien. NOBOX (Newborn Ovary Homeobox) est un facteur de transcription essentiel à la mise en place du stock folliculaire, et dont les mutations sont responsables d’IOP. La fonction exacte de NOBOX n’est pas connue, s’il est présent dans l’ovocyte, nous montrons pour la première fois une forte expression de cette protéine dans les cellules de la granulosa des follicules primordiaux jusqu’au stade secondaire. De plus, par différentes techniques moléculaires, nous mettons en évidence une interaction entre NOBOX et un autre acteur important de la folliculogenèse FOXL2 (Forkhead box l2), contribuant à la régulation de leurs gènes cibles respectifs. Cette étude permet de mettre en lumière le rôle de NOBOX dans les cellules de granulosa. L’IOP est une pathologie touchant 1 % des femmes âgées de moins de 40 ans. Sur le plan ovarien, il y a une déplétion du stock des follicules ou un blocage de la maturation folliculaire. De ce fait, la stérilité est le plus souvent définitive. Une origine génétique de cette maladie est parfois retrouvée avec des mutations des autosomes et/ou du chromosome X, mais dans plus de 80% des cas l’IOP est idiopathique. L’enjeu est donc d’identifier de nouveaux gènes candidats pour cette pathologie. Dans cette étude nous validons la prévalence des mutations du gène NOBOX faisant de ce facteur un des gènes clés de l’IOP. Puis, à l’aide d’une nouvelle technologie : le séquençage multiplex par puces PGMTM ION TORRENT, nous mettons en évidence dans 26% de la cohorte étudiée (100 femmes atteintes d’IOP sporadique primaire ou secondaire) un défaut génétique de 10 gènes, dont 4 nouveaux candidats à l’IOP. De façon intéressante, la présence d’au moins deux gènes mutés chez 9 patientes induit un phénotype plus précoce. Cette étude contribue à une meilleure compréhension de l’origine génétique de l’IOP et met pour la première fois en évidence le phénomène d’oligogénisme chez des patientes en IOP. / Single germline mutations found in women with primary ovarian insufficiency (POI), besides mouse models have provided substantial understanding into the factors involved in differentiation and ovarian development. POI is characterized by amenorrhea with elevated gonadotropin levels, and affects 1% of women before the age of 40 years.Several transcription factors involved in ovary development and folliculogenesis are mutated in reproductive disorders. We have shown a high prevalence of POI cases harboring mutations in the Newborn oogenesis homeobox (NOBOX) gene, which encodes a homeodomain-Containing transcription factor expressed preferentially in oocyte. NOBOX plays a critical role in early folliculogenesis and its absence leads to sterility. In addition to its oocyte localization, we show here that NOBOX is also expressed in granulosa cells (GCs), those surrounding the germ cell. Since NOBOX and FOXL2, a master regulator of GC development (belonging to forkhead family), are co-Expressed in GCs. Here, using several molecular approaches, we have demonstrated that NOBOX and FOXL2 indeed physically interact leading to a down-Regulation of their transactivation capacity. Altogether, these observations highlight a novel role for NOBOX in interaction with FOXL2, and suggest that they may be antagonistic transcription regulators. POI encompasses a heterogeneous spectrum of conditions, through two major mechanisms, follicle dysfunction and follicle depletion. Genetic component such as X chromosome abnormalities, deletions, FMR1 premutations, BMP15 variants, were identified as the first genetic causes of the pathophysiology. Today, the genetic origin of POI is supported by the existence of monogenic forms in humans and animal models but the relevance of several loci for POI pathogenesis should not be ruled out. By means of a next-Generation sequencing , a multiplex (PGM-Ion Torrent technology) sequencing of 19 genes was undertaken in a cohort of 100 nonsyndromic women with POI. In 26 patients, we reported 10 gene defects, among them, missense mutations in 4 new candidates were detected. Our aggregate data suggest that point mutations in these candidate genes are causative of the disease by prediction analysis assays. Two to three gene defects can synergize to produce a more severe phenotype in POI patients than either alone. This study identifies for the first time in a large proportion of POI patients specific sets of germline mutations that, together, may account for this disease. Thus, oligogenicity also has implications for genetic counseling regarding POI.

Le cancer épithélial de l’ovaire (EOC) a la particularité d’être diagnostiqué à un stade avancé chez 75% des patientes et de récidiver dans un grand nombre de cas malgré une bonne réponse initiale à la chimiothérapie, expliquant ainsi son pronostic sombre. Le rôle du microenvironnement tumoral semble être de premier plan dans le développement et la survie des cellules cancéreuses mais il existe encore peu de données concernant les cellules mésenchymateuses souches (MSC). Dans ce travail nous avons donc cherché à déterminer les mécanismes moléculaires entre les MSC et les cellules tumorales ovariennes. Dans la première partie de ce travail, nous avons mis en évidence l’émergence d’un profile pro-métastatique des cellules tumorales ovariennes après contact avec les MSC. Nous avons ensuite développé un modèle d’infiltration tumorale 3D révélant que les MSC augmentaient la dissémination tumorale ovarienne par la sécrétion d’IL6. Enfin nous avons démontré que les MSC étaient capables d’induire chez les cellules tumorales ovariennes un phénotype thermotolérant lié à la sécrétion CXCL12. Ces données vont donc toutes dans le même sens en démontrant les propriétés pro-tumorales des MSC et ouvrent de nouvelles perspectives de thérapies ciblant les interactions entre le stroma et la tumeur. / Patients with epithelial ovarian cancer (EOC) are diagnosed with advanced stage in 75% of cases and most of them will relapse despite a good primary response to chemotherapy, thus explaining the bad prognosis of EOC. While tumor microenvironment seems to play an important role for the development and survival of cancer cells, there is only few data regarding the mesenchymal stem cells (MSC) in EOC. In this work we therefore aimed at identifying the molecular determinant between MSC and ovarian cancer cells. In the first part of this work, we demonstrated that ovarian cancer cells acquired pro-metastatic profile upon contact with MSC. We then showed that MSC could enhance ovarian cancer cells infiltration through IL6 secretion in an amniochorionic membrane based 3D model. Finally we showed that MSC could protect ovarian cancer cells from hyperthermia through CXCL12 secretion. Taken together, our data are concordant to reveal the pro-tumoral properties of MSC. Cytokine inhibitors interrupting the cross-talk between OCC and MSC should now be tested as new therapies for EOC.

Le microenvironnement, composé de différents éléments cellulaires et de la matrice extracellulaire, joue un rôle primordial dans le développement tumoral et la dissémination métastatique. Ainsi, l’étude de ces interactions cellulaires est importante pour que des thérapies ciblées luttent contre la chimiorésistance des cellules tumorales. Ce travail de thèse a pour but d’étudier le rôle du facteur de croissance IGF-I dans la chimiorésistance des cellules du cancer de l’ovaire et des leucémies myéloïdes présente au sein du microenvironnement.Dans un premier temps, nous avons mis en évidence que la chimiorésistance des cellules du cancer de l’ovaire, acquise grâce aux cellules hôtes (hospicells), est liée à la sécrétion de IGF-I par ces cellules. Nous avons également montré que IGF-I est impliqué dans la régulation de certains gènes ABC (MDR-1, MRP1, MRP2, et BCRP) via les voies de STAT3, Jak2, PI3K et ERK.Dans les leucémies myéloïdes, nous avons montré que IGF-I a un effet sur la prolifération des cellules tumorales. Il induit l’expression de la protéine P-gp ainsi que la chimiorésistance des cellules sensibles à la chimiothérapie. Nous avons également déterminé le rôle de IGF-I dans la résistance des cellules leucémiques en présence des hospicells. Ces dernières ont une activité hyperangiogénique in vivo, lié à l’HIF-1 et au VEGF, et inhibent les réponses immunes des lymphocytes T par production de NO.Nous avons déterminé le rôle crucial de MMP-9 dans la migration des cellules résistantes du cancer du sein exprimant la protéine P-gp et dans la formation d’un réseau tubulaire, suggérant un lien existant entre l’expression de P-gp et de MMP-9. / The microenvironment, composed of several cellular elements and extracellular matrix, plays an important role in tumor development and metastasis. Thus, the study of these interactions is important for cell targeted therapies fighting against chemoresistant tumor cells. This thesis aims to investigate the role of growth factor IGF-I in the chemoresistance of ovarian cancer cells and myeloid leukemia, present in the microenvironment.As a first step, we demonstrated that drug resistance of ovarian cancer cells gained by host cells (hospicells) is related to the secretion of IGF-I by these cells. We have also demonstrated that IGF-I is involved in the regulation of genes ABC (MDR-1, MRP1, MRP2, and BCRP) via STAT3, Jak2, PI3K et ERK signaling pathways.In myeloid leukemia, we have shown that IGF-I has an effect on cell proliferation. It induces the expression of P-gp protein and chemoresistance of cells sensitive to chemotherapy. We also determined the role of IGF-I in the resistance of leukemic cells in the presence of hospicells. These cells have an in vivo hyperangiogenic activity, related to HIF-1 and VEGF, and inhibit immune responses of T cells by NO production.We determined the crucial role of MMP-9 in resistant cells migration of breast cancer expressing P-gp protein and in the formation of a tubular network, suggesting a link between the expression of P-gp and MMP-9.

Orientador: José Antônio Dell'Aqua Júnior / Resumo: Com o aumento na produção e na comercialização mundial dos produtos derivados de jumentos, faz-se necessária uma melhor compreensão da espécie. O mercado Chinês, baseado na medicinal tradicional chinesa tem importado asininos do mundo todo, gerando um aumento de 150 % nas importações, abrindo uma novo nicho de mercado mundial. Devido a essa demanda torna se indispensável estudos relacionados com a fisiologia reprodutiva, bem como a correta compreensão dos mecanismos envolvidos na dinâmica ovariana dos asininos, possibilitando assim a utilização de biotecnologias que visam o aumento na eficácia reprodutiva da espécie. A ultrassonografia tem sido amplamente utilizada para o monitoramento dos fenômenos reprodutivos das espécies domésticas, tanto patológicos quanto fisiológico. O corpo lúteo definido como uma glândula transitória, secretora de progesterona e mantenedora da gestação nas espécies monovulátorio como asininos e bovinos . O funcionamento fisiológico do corpo lúteo é dependente de uma microvascularização local, que está diretamente relacionada com os níveis séricos de progesterona. Desta maneira, o presente estudo teve como objetivo o monitoramento dos eventos reprodutivos fisiológicos e comportamentais relacionados a dinâmica folicular associada com o acompanhamento da perfusão luteal períferica e sua relação com as concentrações plásmaticas de estrógeno e progesterona ao longo do ciclo . / Abstract: With the increase in the production and the worldwide commercialization of the derived products of asses, it makes if necessary a better understanding of the species. The Chinese market, based on traditional Chinese medicine has imported asininos from all over the world, generating a 150% increase in imports, and a billion dollar revenue throughout the year. In this way, it becomes indispensable the studies related to the reproductive physiology, as well as the correct understanding of the mechanisms involved in the ovarian dynamics of the asininos, thus allowing the use of biotechnologies that aim at the increase in the reproductive effectiveness of the species. Ultrasonography has been widely used for the monitoring of reproductive phenomena of domestic species, both pathological and physiological. The corpus luteum defined as a transitory gland, secreting progesterone and maintaining gestation. The physiological functioning of the corpus luteum is dependent on local microvascularisation, which is directly related to serum progesterone levels. In this way, the present study aimed to monitor the physiological and behavioral reproductive events related to ovarian dynamics associated with the monitoring of percutaneous luteal perfusion and its relation with estrogen and progesterone concentrations throughout the cycle. / Mestre